Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (28 quarters reported)
$419M in Q4 2016 → $20.6M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Pmv Pharmaceuticals Inc | 48.1% | Unchanged | 1,614,911 | $9.92M |
| The Realreal | 24.1% | Unchanged | 2,354,080 | $4.97M |
| Sera Prognostics | 21.8% | Unchanged | 2,416,241 | $4.49M |
| Glaukos Corp | 6.0% | Unchanged | 16,347 | $1.23M |
| Dare Bioscience Inc | 0.1% | Unchanged | 62,065 | $28.7K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2023 · filed October 20, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed July 21, 2023
No position changes this quarter.
quarter ended March 31, 2023 · filed April 27, 2023
No position changes this quarter.
quarter ended December 31, 2022 · filed January 31, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | Exited | −560,990 | −$4.22M | — |
| AG Applied Genetic Technol Corp | Exited | −1,404,515 | −$381K | — |
| Venus Concept Inc | Exited | −658,657 | −$290K | — |
quarter ended September 30, 2022 · filed October 25, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Glaukos Corp | Trimmed | −334,897 | −$17.8M | 2.7% |
quarter ended June 30, 2022 · filed August 02, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Braze Inc | Exited | −3,394,219 | −$141M | — |
| Pmv Pharmaceuticals Inc | Trimmed | −1,620,000 | −$23.1M | 42.8% |
| Glaukos Corp | Added | +980 | +$44.5K | 29.7% |
quarter ended March 31, 2022 · filed April 13, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Braze Inc | New | +3,394,219 | +$141M | 53.8% |
| C3.ai | Exited | −866,774 | −$27.1M | — |
| Eiger Biopharmaceuticals Inc | Trimmed | −203,928 | −$1.69M | 1.8% |
quarter ended December 31, 2021 · filed January 25, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Pmv Pharmaceuticals Inc | Trimmed | −635,000 | −$14.7M | 44.2% |
| Xenon Pharmaceuticals Inc | Exited | −8,293 | −$127K | — |
Loading...
